| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/14/2011 | EP2364694A1 Controlled-release formulations of pramipexole |
| 09/14/2011 | EP2364692A2 Compositions including at least one derivative of naphtoic acid, benzoyl peroxide and at least one film-forming agent, methods for preparing same and uses thereof |
| 09/14/2011 | EP2364360A1 Antisense compositions and methods of making and using same |
| 09/14/2011 | EP2364330A2 Multiblock copolymers |
| 09/14/2011 | EP2364316A1 6, 7 -dihydro- 5h- pyrrolo [3, 4-d¨pyrimidin-4-yl]-quinolin-3 -ylamine compounds useful as FAAH modulators and uses thereof |
| 09/14/2011 | EP2364314A1 Modulators of toll-like receptors |
| 09/14/2011 | EP2364313A1 Aza-benzimidazolone chymase inhibitors |
| 09/14/2011 | EP2364311A1 Tropane urea derivatives, preparation thereof and therapeutic application thereof as modulators of the activity of 11betahsd1 |
| 09/14/2011 | EP2364308A1 Pyrazine compounds as phosphodiesterase 10 inhibitors |
| 09/14/2011 | EP2364307A1 Synthesis and novel salt forms of (r)-5-((e)-2-(pyrrolidin-3-ylvinyl)pyrimidine |
| 09/14/2011 | EP2364306A1 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors |
| 09/14/2011 | EP2364304A1 Alpha-lipoic acid derivatives and their use in drug preparation |
| 09/14/2011 | EP2364303A1 Aryl piperazine and their use as alpha2c antagonists |
| 09/14/2011 | EP2364300A2 Dimeric 1-arylpyrazole derivatives |
| 09/14/2011 | EP2364299A1 Bis [o-(14-benzoylaconine-8-yl)]esters |
| 09/14/2011 | EP2364298A1 Quinolone compound and pharmaceutical composition |
| 09/14/2011 | EP2364297A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders |
| 09/14/2011 | EP2364296A1 Pyrrolidines |
| 09/14/2011 | EP2364295A1 3-(benzylamino)-pyrrolidine derivatives and their use as nk-3 receptor antagonists |
| 09/14/2011 | EP2364292A2 Amide inhibitors of renin |
| 09/14/2011 | EP2364185A1 Disubstituted phthalazine hedgehog pathway antagonists |
| 09/14/2011 | EP2364164A1 Method and composition for enhancement of male erectile function |
| 09/14/2011 | EP2364161A2 Compositions containing satiogens and methods of use |
| 09/14/2011 | EP2364154A1 Compositions and methods for treating matrix metalloproteinase 9 (mmp9)-mediated conditions |
| 09/14/2011 | EP2364153A1 Chitosan derivatives to treat animals or optimize animal health |
| 09/14/2011 | EP2364152A2 Methods for preparation and use of marrow infiltrating lymphocytes (mils) |
| 09/14/2011 | EP2364151A1 Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury |
| 09/14/2011 | EP2364150A1 Treatment with alpha 7-selective ligands |
| 09/14/2011 | EP2364149A1 Tnik inhibitor and the use |
| 09/14/2011 | EP2364148A1 Combination of rocaglamide and apoptosis inducing substances for the treatment of cancer |
| 09/14/2011 | EP2364147A2 Compositions comprising 1-arylpyrazole alone or in combination with formamidine for the treatment of parasitic infection |
| 09/14/2011 | EP2364146A1 Medicament and method of diagnosis |
| 09/14/2011 | EP2364145A1 Dosage forms for the rapid and sustained elevation of gastric ph |
| 09/14/2011 | EP2364144A2 Dosage form for insertion into the mouth |
| 09/14/2011 | EP2364142A2 Compositions of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto |
| 09/14/2011 | EP2364141A1 Compacted moxifloxacin |
| 09/14/2011 | EP2364140A1 Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester |
| 09/14/2011 | EP2364139A2 Ngna compositions and methods of use |
| 09/14/2011 | EP2364138A2 Palonosetron formulation |
| 09/14/2011 | EP2364098A1 Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals |
| 09/14/2011 | EP2364089A1 Heterobicyclic sphingosine 1-phosphate analogs |
| 09/14/2011 | EP2364088A1 Bicyclic aryl sphingosine 1-phosphate analogs |
| 09/14/2011 | EP2364087A1 7-hydroxy-benzoimidazole-4-yl-methanone derivatives and pbk inhibitors containing the same |
| 09/14/2011 | EP2364086A1 Novel antithrombotic diadenosine tetraphosphates and related analogs |
| 09/14/2011 | EP2364084A1 Low dose lipoic acid pharmaceutical compositions and methods |
| 09/14/2011 | EP2364082A1 Naphthamides as anticancer agents |
| 09/14/2011 | EP2235017B1 Spiroindolinone derivatives as anticancer agents |
| 09/14/2011 | EP2231636B1 Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases |
| 09/14/2011 | EP2225241B1 Derivatives of N-phenyl-imidazo-(1,2-A)-pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/14/2011 | EP2225222B1 A quinoline derivative acting as a p2x7-receptor antagonist |
| 09/14/2011 | EP2203170B1 NOVEL THERAPEUTIC USES OF ADRENERGIC ALFUZOsINE |
| 09/14/2011 | EP2201001B1 Novel imidazole derivatives |
| 09/14/2011 | EP2185530B1 5-phenyl-isoxazole-3-carboxamide derivatives as trpv1 modulators |
| 09/14/2011 | EP2170864B1 Pyridone gpr119 g protein-coupled receptor agonists |
| 09/14/2011 | EP2170104B1 Food composition for prodromal dementia patients |
| 09/14/2011 | EP2164847B1 3-aza-bicyclo[3.3.0]octane compounds |
| 09/14/2011 | EP2139892B1 Substituted pyrimidodiazepines useful as plk1 inhibitors |
| 09/14/2011 | EP2139880B1 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 09/14/2011 | EP2097389B1 Sulfated benzimidazolone derivatives having mixed serotonine receptor affinity |
| 09/14/2011 | EP2089030B1 Agent for prophylaxis or treatment of alcohol dependence or drug dependence |
| 09/14/2011 | EP2086956B1 Inhibitors of ikk- beta serine-threonine protein kinase |
| 09/14/2011 | EP2079731B1 Novel substituted piperidyl-propane-thiols |
| 09/14/2011 | EP2079472B1 High-purity large-scale preparation of stannsoporfin |
| 09/14/2011 | EP2076271B1 Inhibition of cholera toxins by galatooligosaccharides (gos) |
| 09/14/2011 | EP2073816B1 Boronic acids and esters as inhibitors of fatty acid amide hydrolase |
| 09/14/2011 | EP2049664B1 Single stranded oligonucleotides complementary to repetitive elements for treating DNA repeat instability associated genetic disorders |
| 09/14/2011 | EP2049501B1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 09/14/2011 | EP2041151B1 A method of preparing a glycoside of a mono- or diacylglycerol product from a plant material |
| 09/14/2011 | EP2041140B1 Aziridinyl-epothilone compounds |
| 09/14/2011 | EP2007380B1 Use of a kinase inhibitor for the treatment of particular resistant tumors |
| 09/14/2011 | EP1961734B1 Amine compound and use thereof for medical purposes |
| 09/14/2011 | EP1954134B1 Process for synthesizing a 2-phenyl-1h-phenantrho[9,10-d]imidazole derivative |
| 09/14/2011 | EP1948663B1 Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators |
| 09/14/2011 | EP1926768B1 Branched functionalized polymers using branched polyol cores |
| 09/14/2011 | EP1926727B1 4-chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof |
| 09/14/2011 | EP1912997B1 Macrocyclic inhibitors of hepatitis c virus |
| 09/14/2011 | EP1911755B1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 09/14/2011 | EP1909773B1 Transdermal system for varenicline |
| 09/14/2011 | EP1906766B1 Low-glycemic mixtures |
| 09/14/2011 | EP1904054B1 Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity |
| 09/14/2011 | EP1893620B1 Substituted spiro compounds and their use for producing pain-relief drugs |
| 09/14/2011 | EP1893589B1 Substituted n-benzo [d] isoxazol-3-yl-amine derivatives as inhibitors of mglur5, serotonine (5-ht) and noradrenaline receptors, and the use thereof for producing medicaments |
| 09/14/2011 | EP1893211B1 Use of sanglifehrin in hcv |
| 09/14/2011 | EP1890707B1 Nutritional supplement with colostrum and epa and optionally dha or gla |
| 09/14/2011 | EP1877556B1 Use of anti-tnf or anti-il1 rnai to suppress pro- inflammatory cytokine actions locally to treat pain |
| 09/14/2011 | EP1874769B1 Novel aza- heterocycles serving as kinase inhibitors |
| 09/14/2011 | EP1871374B1 2,3 substituted pyrazine sulfonamides as inhibitors of crth2 |
| 09/14/2011 | EP1865931B1 Transdermal patch |
| 09/14/2011 | EP1853241B1 Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3- cyclohexanedione in the treatment of parkinson's disease |
| 09/14/2011 | EP1809288B1 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases |
| 09/14/2011 | EP1773757B1 Trpv1 agonists, formulations containing them and uses thereof |
| 09/14/2011 | EP1747777B1 Medicinal agent |
| 09/14/2011 | EP1740535B1 Thio-substituted arylmethanesulfinyl derivatives |
| 09/14/2011 | EP1735322B1 Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful for the treatment of type 2 diabetes |
| 09/14/2011 | EP1727820B1 Amine derivatives with tyrosinkinase inhibiting activity |
| 09/14/2011 | EP1713480B1 The use of quaternary pyridinium salts as vasoprotective agents |
| 09/14/2011 | EP1689387B1 Bicyclic inhibitors of mek and methods of synthesis thereof |
| 09/14/2011 | EP1631234B1 Compositions and methods for the treatment of cns injuries |
| 09/14/2011 | EP1605752B1 Sulfonamides for the treatment of congestive heart failure, their compositions and uses. |
| 09/14/2011 | EP1559716B1 Pyrazolonaphthyridine derivative |